Brain Tumor Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Brain Tumor stocks.

Brain Tumor Stocks Recent News

Date Stock Title
May 2 NVCR NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript
May 2 NVCR NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation
May 2 NVCR NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
May 2 NVCR NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
May 2 NVCR Novocure secures new $400M multi-tranche debt financing, shares up
May 2 NVCR NovoCure GAAP EPS of -$0.36 beats by $0.06, revenue of $138.5M beats by $7.05M
May 2 NVCR Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
May 2 NVCR Novocure Reports First Quarter 2024 Financial Results
May 1 NVCR NovoCure Q1 2024 Earnings Preview
Apr 30 BDRX Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting
Apr 29 SHPH Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
Apr 29 BDRX Why Philips Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket
Apr 26 BDRX Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Apr 26 BDRX Biodexa shares rally 126% on rapamycin licensing deal
Apr 26 BDRX US Stocks Higher Following PCE Inflation Data; Nasdaq Jumps Over 200 Points
Apr 26 BDRX Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)
Apr 26 YMAB Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024
Brain Tumor

A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors, which start within the brain, and secondary tumors, which have spread from elsewhere, known as brain metastasis tumors. All types of brain tumors may produce symptoms that vary depending on the part of the brain involved. These symptoms may include headaches, seizures, problems with vision, vomiting and mental changes. The headache is classically worse in the morning and goes away with vomiting. Other symptoms may include difficulty walking, speaking or with sensations. As the disease progresses, unconsciousness may occur.The cause of most brain tumors is unknown. Uncommon risk factors include inherited neurofibromatosis, exposure to vinyl chloride, Epstein–Barr virus and ionizing radiation. The evidence for mobile phone exposure is not clear. The most common types of primary tumors in adults are meningiomas (usually benign) and astrocytomas such as glioblastomas. In children, the most common type is a malignant medulloblastoma. Diagnosis is usually by medical examination along with computed tomography or magnetic resonance imaging. The result is then often confirmed by a biopsy. Based on the findings, the tumors are divided into different grades of severity.Treatment may include some combination of surgery, radiation therapy and chemotherapy. Anticonvulsant medication may be needed if seizures occur. Dexamethasone and furosemide may be used to decrease swelling around the tumor. Some tumors grow gradually, requiring only monitoring and possibly needing no further intervention. Treatments that use a person's immune system are being studied. Outcome varies considerably depending on the type of tumor and how far it has spread at diagnosis. Glioblastomas usually have poor outcomes, while meningiomas usually have good outcomes. The average five-year survival rate for all brain cancers in the United States is 33%.Secondary, or metastatic, brain tumors are more common than primary brain tumors, with about half of metastases coming from lung cancer. Primary brain tumors occur in around 250,000 people a year globally, making up less than 2% of cancers. In children younger than 15, brain tumors are second only to acute lymphoblastic leukemia as the most common form of cancer. In Australia, the average lifetime economic cost of a case of brain cancer is $1.9 million, the greatest of any type of cancer.

Browse All Tags